Schedule 13D ownership disclosure
PROTEON THERAPEUTICS INC
Security class unavailable · CUSIP: 74371L109
Event date: 2014-10-21
Legacy cover-page extraction is best effort and may not include every reporting person.
- Filing-level shares
- 2,017,872
- Percent of class
- 13.5000%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0000905718-14-000715
- Form type
- SC 13D
- Filer
- Abingworth LLP
- CIK
- CIK 1397144
- Filed
- Oct 31, 2014
- Reporting period
- Oct 21, 2014
- Description
- Schedule 13D beneficial ownership